The significant enrichment of the “Cell cycle” pathway across these modules highlights the importance of CDK1 and CDC20 in NSCLC, as their dysregulation contributes to tumor aggressiveness and resistance to treatment [54]. The gene discussed is CDK1; the disease is non-small cell lung carcinoma.